Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers (Q79134567)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

19 March 2024

author name string

Tomonori Habuchi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Toshiyuki Kamoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Isao Hara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Koji Kawai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Masahiro Nakao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Norio Nonomura

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Takashi Kobayashi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Osamu Ogawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Sadao Kamidono

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Hideyuki Akaza

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Akihiko Okuyama

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Tetsuro Kato

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Tsuneharu Miki

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14534879

19 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

15 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14534879

full work available at URL

19 March 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.11711

1 reference

https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.11711

19 March 2024

1 reference

19 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

1635-1642

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11711

7 January 2021

High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11711

7 January 2021

Results of treatment after relapse from high-dose chemotherapy in germ cell tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11711

7 January 2021

Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11711

7 January 2021

Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11711

7 January 2021

Surgical salvage of chemorefractory germ cell tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11711

7 January 2021

Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11711

7 January 2021

Results of salvage retroperitoneal lymphadenectomy (RLA) in the treatment of patients with nonseminomatous germ cell tumours remaining marker positive after inductive chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11711

7 January 2021

False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11711

7 January 2021

Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11711

7 January 2021

False elevations of human chorionic gonadotropin associated to iatrogenic hypogonadism in gonadal germ cell tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11711

7 January 2021

Post-chemotherapy resection of nonseminomatous germ cell testicular tumors metastatic to the mediastinum

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11711

7 January 2021

VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11711

7 January 2021

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11711

7 January 2021

High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11711

7 January 2021

POMB/ACE chemotherapy in non-seminomatous germ cell tumours: outcome and importance of dose intensity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11711

7 January 2021

Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors

1

1 reference

19 March 2024

Identifiers

DOI

10.1002/CNCR.11711

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14534879%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference